{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T04:12:46Z","timestamp":1793938366924,"version":"4.8.0"},"reference-count":122,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000093","name":"U.S. Department of Health & Human Services | NIH | Center for Information Technology","doi-asserted-by":"publisher","award":["ZIA BC 011744"],"award-info":[{"award-number":["ZIA BC 011744"]}],"id":[{"id":"10.13039\/100000093","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Leucine-rich repeat kinase 2 (LRRK2) is an essential regulator in cellular signaling and a major contributor to Parkinson\u2019s disease (PD) pathogenesis. 14-3-3 proteins are critical modulators of LRRK2 activity, yet the structural basis of their interaction has remained unclear. Here, we present the cryo-electron microscopy structure of the LRRK2:14-3-3\n                    <jats:sub>2<\/jats:sub>\n                    autoinhibitory complex, revealing how a 14-3-3 dimer stabilizes an autoinhibited LRRK2 monomer through dual-site anchoring. The dimer engages both phosphorylated S910\/S935 sites and the COR-A\/B subdomains within the Roc-COR GTPase region. This spatial configuration constrains LRR domain mobility, reinforces the inactive conformation, and likely impedes LRRK2 dimerization and oligomer formation. Structure-guided mutagenesis studies show that PD-associated mutations at the COR:14-3-3\n                    <jats:sub>2<\/jats:sub>\n                    interface and within the GTPase domain weaken 14-3-3 binding and impair its inhibitory effect on LRRK2 kinase activity. Furthermore, we demonstrate that type I LRRK2 kinase inhibitor, which stabilizes the kinase domain in its active conformation, reduces 14-3-3 binding and promotes dephosphorylation at pS910 and pS935. Together, these findings provide a structural basis for understanding how LRRK2 is maintained in an inactive state, elucidate the mechanistic role of 14-3-3 in LRRK2 regulation, inform the interpretation of PD biomarkers, and suggest therapeutic strategies aimed at enhancing LRRK2-14-3-3 interactions to treat PD and related disorders.\n                  <\/jats:p>","DOI":"10.1038\/s41467-025-62337-1","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T18:13:22Z","timestamp":1754417602000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["14-3-3 binding maintains the Parkinson\u2019s associated kinase LRRK2 in an inactive state"],"prefix":"10.1038","volume":"16","author":[{"given":"Juliana A.","family":"Martinez Fiesco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Beilina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5787-8519","authenticated-orcid":false,"given":"Astrid","family":"Alvarez de la Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5202-2075","authenticated-orcid":false,"given":"Ning","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7154-780X","authenticated-orcid":false,"given":"Riley D.","family":"Metcalfe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1058-3831","authenticated-orcid":false,"given":"Mark R.","family":"Cookson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0340-281X","authenticated-orcid":false,"given":"Ping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,5]]},"reference":[{"key":"62337_CR1","doi-asserted-by":"publisher","unstructured":"Gasser, T. Molecular pathogenesis of Parkinson disease: insights from genetic studies. Expert Rev. Mol. Med. https:\/\/doi.org\/10.1017\/S1462399409001148 (2009).","DOI":"10.1017\/S1462399409001148"},{"key":"62337_CR2","doi-asserted-by":"publisher","first-page":"e1002548","DOI":"10.1371\/journal.pgen.1002548","volume":"8","author":"CM Lill","year":"2012","unstructured":"Lill, C. M. et al. Comprehensive research synopsis and systematic meta-analyses in Parkinson\u2019s disease genetics: The PDGene Database. PLoS Genet. 8, e1002548 (2012).","journal-title":"PLoS Genet."},{"key":"62337_CR3","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/S1474-4422(11)70175-2","volume":"10","author":"OA Ross","year":"2011","unstructured":"Ross, O. A. et al. Association of LRRK2 exonic variants with susceptibility to Parkinson\u2019s disease: a case\u2013control study.  Lancet Neurol. 10, 898\u2013908 (2011).","journal-title":"Lancet Neurol."},{"key":"62337_CR4","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1038\/ng.485","volume":"41","author":"W Satake","year":"2009","unstructured":"Satake, W. et al. Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson\u2019s disease. Nat. Genet. 41, 1303\u20131307 (2009).","journal-title":"Nat. Genet."},{"key":"62337_CR5","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1038\/ng.487","volume":"41","author":"J Sim\u00f3n-S\u00e1nchez","year":"2009","unstructured":"Sim\u00f3n-S\u00e1nchez, J. et al. Genome-wide association study reveals genetic risk underlying Parkinson\u2019s disease. Nat. Genet. 41, 1308\u20131312 (2009).","journal-title":"Nat. Genet."},{"key":"62337_CR6","doi-asserted-by":"publisher","first-page":"16842","DOI":"10.1073\/pnas.0507360102","volume":"102","author":"AB West","year":"2005","unstructured":"West, A. B. et al. Parkinson\u2019s disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity. Proc. Natl. Acad. Sci. USA 102, 16842\u201316847 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"62337_CR7","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.neuron.2004.11.005","volume":"44","author":"A Zimprich","year":"2004","unstructured":"Zimprich, A. et al. Mutations in LRRK2 cause autosomal-dominant Parkinsonism with pleomorphic pathology. Neuron 44, 601\u2013607 (2004).","journal-title":"Neuron"},{"key":"62337_CR8","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1093\/hmg\/dds522","volume":"22","author":"A Biosa","year":"2013","unstructured":"Biosa, A. et al. GTPase activity regulates kinase activity and cellular phenotypes of Parkinson\u2019s disease-associated LRRK2. Hum. Mol. Genet. 22, 1140\u20131156 (2013).","journal-title":"Hum. Mol. Genet."},{"key":"62337_CR9","doi-asserted-by":"publisher","first-page":"e43472","DOI":"10.1371\/journal.pone.0043472","volume":"7","author":"L Civiero","year":"2012","unstructured":"Civiero, L. et al. Biochemical characterization of highly purified leucine-rich repeat kinases 1 and 2 demonstrates formation of homodimers. PLoS ONE 7, e43472 (2012).","journal-title":"PLoS ONE"},{"key":"62337_CR10","doi-asserted-by":"publisher","unstructured":"Gilsbach, B. K. & Kortholt, A. Structural biology of the LRRK2 GTPase and kinase domains: implications for regulation. Front. Mol. Neurosci. https:\/\/doi.org\/10.3389\/fnmol.2014.00032 (2014).","DOI":"10.3389\/fnmol.2014.00032"},{"key":"62337_CR11","doi-asserted-by":"publisher","first-page":"16906","DOI":"10.1074\/jbc.M708718200","volume":"283","author":"E Greggio","year":"2008","unstructured":"Greggio, E. et al. The Parkinson disease-associated leucine-rich repeat kinase 2 (LRRK2) is a dimer that undergoes intramolecular autophosphorylation. J. Biol. Chem. 283, 16906\u201316914 (2008).","journal-title":"J. Biol. Chem."},{"key":"62337_CR12","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1021\/bi061960m","volume":"46","author":"G Ito","year":"2007","unstructured":"Ito, G. et al. GTP binding is essential to the protein kinase activity of LRRK2, a causative gene product for familial Parkinson\u2019s disease. Biochemistry 46, 1380\u20131388 (2007).","journal-title":"Biochemistry"},{"key":"62337_CR13","doi-asserted-by":"publisher","unstructured":"Sheng, Z. J. et al. Ser1292 autophosphorylation is an indicator of LRRK2 kinase activity and contributes to the cellular effects of PD mutations. Sci. Transl. Med. https:\/\/doi.org\/10.1126\/scitranslmed.3004485 (2012).","DOI":"10.1126\/scitranslmed.3004485"},{"key":"62337_CR14","doi-asserted-by":"publisher","first-page":"e23207","DOI":"10.1371\/journal.pone.0023207","volume":"6","author":"J-M Taymans","year":"2011","unstructured":"Taymans, J.-M. et al. LRRK2 kinase activity is dependent on LRRK2 GTP binding capacity but independent of LRRK2 GTP binding. PLoS ONE 6, e23207 (2011).","journal-title":"PLoS ONE"},{"key":"62337_CR15","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1006\/jsbi.2001.4392","volume":"134","author":"MA Andrade","year":"2001","unstructured":"Andrade, M. A., Perez-Iratxeta, C. & Ponting, C. P. Protein repeats: structures, functions, and evolution. J. Struct. Biol. 134, 117\u2013131 (2001).","journal-title":"J. Struct. Biol."},{"key":"62337_CR16","first-page":"5","volume":"1643","author":"L Bosgraaf","year":"2003","unstructured":"Bosgraaf, L. & Van Haastert, P. J. M. Roc, a Ras\/GTPase domain in complex proteins. Biochim. Biophys. Mol. Cell Res. 1643, 5\u201310 (2003).","journal-title":"Biochim. Biophys. Mol. Cell Res."},{"key":"62337_CR17","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.1096\/fj.08-111310","volume":"22","author":"I Marin","year":"2008","unstructured":"Marin, I., van Egmond, W. N. & van Haastert, P. J. The Roco protein family: a functional perspective. FASEB J. 22, 3103\u20133110 (2008).","journal-title":"FASEB J."},{"key":"62337_CR18","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.tins.2006.03.006","volume":"29","author":"IF Mata","year":"2006","unstructured":"Mata, I. F., Wedemeyer, W. J., Farrer, M. J., Taylor, J. P. & Gallo, K. A. LRRK2 in Parkinson\u2019s disease: protein domains and functional insights. Trends Neurosci. 29, 286\u2013293 (2006).","journal-title":"Trends Neurosci."},{"key":"62337_CR19","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/humu.22515","volume":"35","author":"RD Mills","year":"2014","unstructured":"Mills, R. D., Mulhern, T. D., Liu, F., Culvenor, J. G. & Cheng, H. C. Prediction of the repeat domain structures and impact of Parkinsonism-associated variations on structure and function of all functional domains of leucine-rich repeat kinase 2 (LRRK2). Hum. Mutat. 35, 395\u2013412 (2014).","journal-title":"Hum. Mutat."},{"key":"62337_CR20","doi-asserted-by":"publisher","unstructured":"Madureira, M., Connor-Robson, N. & Wade-Martins, R. \u201cLRRK2: autophagy and lysosomal activity\u201d. Front. Neurosci. https:\/\/doi.org\/10.3389\/fnins.2020.00498 (2020).","DOI":"10.3389\/fnins.2020.00498"},{"key":"62337_CR21","doi-asserted-by":"publisher","unstructured":"Roosen, D. A. & Cookson, M. R. LRRK2 at the interface of autophagosomes, endosomes and lysosomes. Mol. Neurodegener. https:\/\/doi.org\/10.1186\/s13024-016-0140-1 (2016).","DOI":"10.1186\/s13024-016-0140-1"},{"key":"62337_CR22","doi-asserted-by":"publisher","unstructured":"Steger, M. et al. Phosphoproteomics reveals that Parkinson\u2019s disease kinase LRRK2 regulates a subset of Rab GTPases. eLife https:\/\/doi.org\/10.7554\/eLife.12813 (2016).","DOI":"10.7554\/eLife.12813"},{"key":"62337_CR23","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.ceb.2020.01.001","volume":"63","author":"M Taylor","year":"2020","unstructured":"Taylor, M. & Alessi, D. R. Advances in elucidating the function of leucine-rich repeat protein kinase-2 in normal cells and Parkinson\u2019s disease. Curr. Opin. Cell Biol. 63, 102\u2013113 (2020).","journal-title":"Curr. Opin. Cell Biol."},{"key":"62337_CR24","doi-asserted-by":"publisher","first-page":"e0175424","DOI":"10.1371\/journal.pone.0175424","volume":"12","author":"M Artzi","year":"2017","unstructured":"Artzi, M. et al. DaT-SPECT assessment depicts dopamine depletion among asymptomatic G2019S LRRK2 mutation carriers. PLoS ONE 12, e0175424 (2017).","journal-title":"PLoS ONE"},{"key":"62337_CR25","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/j.1471-4159.2010.07105.x","volume":"116","author":"V Dani\u00ebls","year":"2011","unstructured":"Dani\u00ebls, V. et al. Insight into the mode of action of the LRRK2 Y1699C pathogenic mutant. J. Neurochem.116, 304\u2013315 (2011).","journal-title":"J. Neurochem."},{"key":"62337_CR26","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1002\/ana.10113","volume":"51","author":"M Funayama","year":"2002","unstructured":"Funayama, M. et al. A new locus for Parkinson\u2019s disease (PARK8) maps to chromosome 12p11.2\u2013q13.1. Ann. Neurol. 51, 296\u2013301 (2002).","journal-title":"Ann. Neurol."},{"key":"62337_CR27","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1042\/BJ20070209","volume":"405","author":"M Jaleel","year":"2007","unstructured":"Jaleel, M. et al. LRRK2 phosphorylates moesin at threonine-558: characterization of how Parkinson\u2019s disease mutants affect kinase activity. Biochem. J. 405, 307\u2013317 (2007).","journal-title":"Biochem. J."},{"key":"62337_CR28","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1042\/BCJ20180589","volume":"476","author":"E Leandrou","year":"2019","unstructured":"Leandrou, E. et al. Kinase activity of mutant LRRK2 manifests differently in hetero-dimeric vs. homo-dimeric complexes. Biochem. J. 476, 559\u2013579 (2019).","journal-title":"Biochem. J."},{"key":"62337_CR29","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.bbrc.2007.04.006","volume":"357","author":"PA Lewis","year":"2007","unstructured":"Lewis, P. A. et al. The R1441C mutation of LRRK2 disrupts GTP hydrolysis. Biochem. Biophys. Res. Commun. 357, 668\u2013671 (2007).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"62337_CR30","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.neuron.2004.10.023","volume":"44","author":"C Pais\u00e1n-Ru\u0131\u0301Z","year":"2004","unstructured":"Pais\u00e1n-Ru\u0131\u0301Z, C. et al. Cloning of the gene containing mutations that cause PARK8-linked Parkinson\u2019s disease. Neuron 44, 595\u2013600 (2004).","journal-title":"Neuron"},{"key":"62337_CR31","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1042\/BJ20091035","volume":"424","author":"RJ Nichols","year":"2009","unstructured":"Nichols, R. J. et al. Substrate specificity and inhibitors of LRRK2, a protein kinase mutated in Parkinson\u2019s disease. Biochem. J. 424, 47\u201360 (2009).","journal-title":"Biochem. J."},{"key":"62337_CR32","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.2174\/1570159X16666180222165418","volume":"16","author":"Q Rui","year":"2018","unstructured":"Rui, Q., Ni, H., Li, D., Gao, R. & Chen, G. The role of LRRK2 in neurodegeneration of Parkinson disease. Curr. Neuropharmacol. 16, 1348\u20131357 (2018).","journal-title":"Curr. Neuropharmacol."},{"key":"62337_CR33","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1093\/hmg\/ddl471","volume":"16","author":"AB West","year":"2007","unstructured":"West, A. B. et al. Parkinson\u2019s disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity. Hum. Mol. Genet. 16, 223\u2013232 (2007).","journal-title":"Hum. Mol. Genet."},{"key":"62337_CR34","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1001\/jamaneurol.2014.1973","volume":"72","author":"I Agalliu","year":"2015","unstructured":"Agalliu, I. et al. Higher frequency of certain cancers in LRRK2 G2019S mutation carriers with Parkinson disease. JAMA Neurol. 72, 58 (2015).","journal-title":"JAMA Neurol."},{"key":"62337_CR35","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1111\/bph.15575","volume":"179","author":"S Azeggagh","year":"2022","unstructured":"Azeggagh, S. & Berwick, D. C. The development of inhibitors of leucine-rich repeat kinase 2 (LRRK2) as a therapeutic strategy for Parkinson\u2019s disease: the current state of play. Br. J. Pharmacol. 179, 1478\u20131495 (2022).","journal-title":"Br. J. Pharmacol."},{"key":"62337_CR36","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1212\/WNL.0b013e318249f673","volume":"78","author":"R Inzelberg","year":"2012","unstructured":"Inzelberg, R. et al. The G2019S mutation is associated with Parkinson disease and concomitant non-skin cancers. Neurology 78, 781\u2013786 (2012).","journal-title":"Neurology"},{"key":"62337_CR37","doi-asserted-by":"publisher","unstructured":"Lebovitz, C. et al. Loss of Parkinson\u2019s susceptibility gene LRRK2 promotes carcinogen-induced lung tumorigenesis. Sci. Rep. https:\/\/doi.org\/10.1038\/s41598-021-81639-0 (2021).","DOI":"10.1038\/s41598-021-81639-0"},{"key":"62337_CR38","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1002\/mds.23314","volume":"25","author":"R Saunders-Pullman","year":"2010","unstructured":"Saunders-Pullman, R. et al. LRRK2 G2019S mutations are associated with an increased cancer risk in Parkinson disease. Mov. Disord. 25, 2536\u20132541 (2010).","journal-title":"Mov. Disord."},{"key":"62337_CR39","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1177\/1073858418756309","volume":"24","author":"T De Wit","year":"2018","unstructured":"De Wit, T., Baekelandt, V. & Lobbestael, E. LRRK2 phosphorylation: behind the scenes. Neuroscientist 24, 486\u2013500 (2018).","journal-title":"Neuroscientist"},{"key":"62337_CR40","doi-asserted-by":"publisher","unstructured":"Marchand, A., Drouyer, M., Sarchione, A., Chartier-Harlin, M.-C. & Taymans, J.-M. LRRK2 phosphorylation, more than an epiphenomenon. Front. Neurosci. https:\/\/doi.org\/10.3389\/fnins.2020.00527 (2020).","DOI":"10.3389\/fnins.2020.00527"},{"key":"62337_CR41","doi-asserted-by":"crossref","unstructured":"Civiero, L., Russo, I., Bubacco, L. & Greggio, E. Molecular insights and functional implication of LRRK2 dimerization. Adv. Neurobiol. 14, 107\u2013121 (2017).","DOI":"10.1007\/978-3-319-49969-7_6"},{"key":"62337_CR42","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/s41586-020-2673-2","volume":"588","author":"CK Deniston","year":"2020","unstructured":"Deniston, C. K. et al. Structure of LRRK2 in Parkinson\u2019s disease and model for microtubule interaction. Nature 588, 344\u2013349 (2020).","journal-title":"Nature"},{"key":"62337_CR43","doi-asserted-by":"publisher","first-page":"E4357","DOI":"10.1073\/pnas.1523708113","volume":"113","author":"G Guaitoli","year":"2016","unstructured":"Guaitoli, G. et al. Structural model of the dimeric Parkinson\u2019s protein LRRK2 reveals a compact architecture involving distant interdomain contacts. Proc. Natl. Acad. Sci. USA 113, E4357\u2013E4366 (2016).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"62337_CR44","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1093\/hmg\/ddr526","volume":"21","author":"LR Kett","year":"2012","unstructured":"Kett, L. R. et al. LRRK2 Parkinson disease mutations enhance its microtubule association. Hum. Mol. Genet. 21, 890\u2013899 (2012).","journal-title":"Hum. Mol. Genet."},{"key":"62337_CR45","doi-asserted-by":"publisher","first-page":"3519","DOI":"10.1016\/j.cell.2021.05.004","volume":"184","author":"A Myasnikov","year":"2021","unstructured":"Myasnikov, A. et al. Structural analysis of the full-length human LRRK2. Cell 184, 3519\u20133527.e3510 (2021).","journal-title":"Cell"},{"key":"62337_CR46","doi-asserted-by":"publisher","unstructured":"Sejwal, K. et al. Cryo-EM analysis of homodimeric full-length LRRK2 and LRRK1 protein complexes. Sci. Rep. https:\/\/doi.org\/10.1038\/s41598-017-09126-z (2017).","DOI":"10.1038\/s41598-017-09126-z"},{"key":"62337_CR47","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1016\/j.cell.2020.08.004","volume":"182","author":"R Watanabe","year":"2020","unstructured":"Watanabe, R. et al. The in situ structure of Parkinson\u2019s disease-linked LRRK2. Cell 182, 1508\u20131518.e1516 (2020).","journal-title":"Cell"},{"key":"62337_CR48","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1073\/pnas.1817889116","volume":"116","author":"P Zhang","year":"2019","unstructured":"Zhang, P. et al. Crystal structure of the WD40 domain dimer of LRRK2. Proc. Natl. Acad. Sci. USA 116, 1579\u20131584 (2019).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"62337_CR49","doi-asserted-by":"publisher","first-page":"612","DOI":"10.3390\/biom13040612","volume":"13","author":"X Zhang","year":"2023","unstructured":"Zhang, X. & Kortholt, A. LRRK2 structure-based activation mechanism and pathogenesis. Biomolecules 13, 612 (2023).","journal-title":"Biomolecules"},{"key":"62337_CR50","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1126\/science.adi9926","volume":"382","author":"H Zhu","year":"2023","unstructured":"Zhu, H. et al. Rab29-dependent asymmetrical activation of leucine-rich repeat kinase 2. Science 382, 1404\u20131411 (2023).","journal-title":"Science"},{"key":"62337_CR51","doi-asserted-by":"publisher","unstructured":"Bonet-Ponce, L. et al. LRRK2 mediates tubulation and vesicle sorting from lysosomes. Sci. Adv. https:\/\/doi.org\/10.1126\/sciadv.abb2454 (2020).","DOI":"10.1126\/sciadv.abb2454"},{"key":"62337_CR52","doi-asserted-by":"publisher","first-page":"E9115","DOI":"10.1073\/pnas.1812196115","volume":"115","author":"T Eguchi","year":"2018","unstructured":"Eguchi, T. et al. LRRK2 and its substrate Rab GTPases are sequentially targeted onto stressed lysosomes and maintain their homeostasis. Proc. Natl. Acad. Sci. USA 115, E9115\u2013E9124 (2018).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"62337_CR53","doi-asserted-by":"publisher","unstructured":"Herbst, S. et al. LRRK 2 activation controls the repair of damaged endomembranes in macrophages. EMBO J. https:\/\/doi.org\/10.15252\/embj.2020104494 (2020).","DOI":"10.15252\/embj.2020104494"},{"key":"62337_CR54","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1093\/hmg\/ddx410","volume":"27","author":"Z Liu","year":"2018","unstructured":"Liu, Z. et al. LRRK2 phosphorylates membrane-bound Rabs and is activated by GTP-bound Rab7L1 to promote recruitment to the trans-Golgi network. Hum. Mol. Genet. 27, 385\u2013395 (2018).","journal-title":"Hum. Mol. Genet."},{"key":"62337_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15252\/embj.201798099","volume":"37","author":"E Purlyte","year":"2018","unstructured":"Purlyte, E. et al. Rab29 activation of the Parkinson\u2019s disease-associated LRRK2 kinase.  EMBO J. 37, 1\u201318 (2018).","journal-title":"EMBO J."},{"key":"62337_CR56","doi-asserted-by":"publisher","unstructured":"Wang, X. et al. Rab12 is a regulator of LRRK2 and its activation by damaged lysosomes. eLife https:\/\/doi.org\/10.7554\/eLife.87255 (2023).","DOI":"10.7554\/eLife.87255"},{"key":"62337_CR57","doi-asserted-by":"publisher","first-page":"e5949","DOI":"10.1371\/journal.pone.0005949","volume":"4","author":"X Ding","year":"2009","unstructured":"Ding, X. & Goldberg, M. S. Regulation of LRRK2 stability by the E3 ubiquitin ligase CHIP. PLoS ONE 4, e5949 (2009).","journal-title":"PLoS ONE"},{"key":"62337_CR58","doi-asserted-by":"publisher","unstructured":"Gloeckner, C. J. & Porras, P. Guilt-by-association \u2013 functional insights gained from studying the LRRK2 interactome. Front. Neurosci. https:\/\/doi.org\/10.3389\/fnins.2020.00485 (2020).","DOI":"10.3389\/fnins.2020.00485"},{"key":"62337_CR59","doi-asserted-by":"publisher","first-page":"e111632","DOI":"10.1371\/journal.pone.0111632","volume":"9","author":"D Waschb\u00fcsch","year":"2014","unstructured":"Waschb\u00fcsch, D. et al. LRRK2 transport is regulated by its novel interacting partner Rab32. PLoS ONE 9, e111632 (2014).","journal-title":"PLoS ONE"},{"key":"62337_CR60","doi-asserted-by":"publisher","first-page":"3384","DOI":"10.1523\/JNEUROSCI.0185-08.2008","volume":"28","author":"L Wang","year":"2008","unstructured":"Wang, L. et al. The Chaperone Activity of Heat Shock Protein 90 Is Critical for Maintaining the Stability of Leucine-Rich Repeat Kinase 2.  J. Neurosci. 28, 3384\u20133391 (2008).","journal-title":"J. Neurosci."},{"key":"62337_CR61","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1042\/BJ20100784","volume":"430","author":"N Dzamko","year":"2010","unstructured":"Dzamko, N. et al. Inhibition of LRRK2 kinase activity leads to dephosphorylation of Ser910\/Ser935, disruption of 14-3-3 binding and altered cytoplasmic localization. Biochem. J. 430, 405\u2013413 (2010).","journal-title":"Biochem. J."},{"key":"62337_CR62","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1042\/BJ20141305","volume":"469","author":"J Zhao","year":"2015","unstructured":"Zhao, J. & Tyler, J.&R. LRRK2 dephosphorylation increases its ubiquitination. Biochem. J. 469, 107\u2013120 (2015).","journal-title":"Biochem. J."},{"key":"62337_CR63","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/S0006-291X(02)02902-9","volume":"300","author":"M Chaudhri","year":"2003","unstructured":"Chaudhri, M., Scarabel, M. & Aitken, A. Mammalian and yeast 14-3-3 isoforms form distinct patterns of dimers in vivo. Biochem. Biophys. Res. Commun. 300, 679\u2013685 (2003).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"62337_CR64","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0014-5793(95)00598-4","volume":"368","author":"DH Jones","year":"1995","unstructured":"Jones, D. H., Ley, S. & Aitken, A. Isoforms of 14-3-3 protein can form homo- and heterodimers in vivo and in vitro: implications for function as adapter proteins. FEBS Lett. 368, 55\u201358 (1995).","journal-title":"FEBS Lett."},{"key":"62337_CR65","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.semcdb.2011.08.009","volume":"22","author":"AK Freeman","year":"2011","unstructured":"Freeman, A. K. & Morrison, D. K. 14-3-3 Proteins: diverse functions in cell proliferation and cancer progression. Semin. Cell Dev. Biol. 22, 681\u2013687 (2011).","journal-title":"Semin. Cell Dev. Biol."},{"key":"62337_CR66","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.semcdb.2011.09.008","volume":"22","author":"AK Gardino","year":"2011","unstructured":"Gardino, A. K. & Yaffe, M. B. 14-3-3 proteins as signaling integration points for cell cycle control and apoptosis. Semin. Cell Dev. Biol. 22, 688\u2013695 (2011).","journal-title":"Semin. Cell Dev. Biol."},{"key":"62337_CR67","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.cellsig.2016.12.007","volume":"31","author":"A Kaplan","year":"2017","unstructured":"Kaplan, A., Bueno, M. & Fournier, A. E. Extracellular functions of 14-3-3 adaptor proteins. Cell Signal 31, 26\u201330 (2017).","journal-title":"Cell Signal"},{"key":"62337_CR68","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1042\/bst0300360","volume":"30","author":"SC Masters","year":"2002","unstructured":"Masters, S. C. et al. Survival-promoting functions of 14-3-3 proteins. Biochem. Soc. Trans. 30, 360\u2013365 (2002).","journal-title":"Biochem. Soc. Trans."},{"key":"62337_CR69","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.semcdb.2011.09.001","volume":"22","author":"T Obsil","year":"2011","unstructured":"Obsil, T. & Obsilova, V. Structural basis of 14-3-3 protein functions. Semin. Cell Dev. Biol. 22, 663\u2013672 (2011).","journal-title":"Semin. Cell Dev. Biol."},{"key":"62337_CR70","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/376188a0","volume":"376","author":"B Xiao","year":"1995","unstructured":"Xiao, B. et al. Structure of a 14-3-3 protein and implications for coordination of multiple signalling pathways. Nature 376, 188\u2013191 (1995).","journal-title":"Nature"},{"key":"62337_CR71","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1042\/BJ20100483","volume":"430","author":"RJ Nichols","year":"2010","unstructured":"Nichols, R. J. et al. 14-3-3 binding to LRRK2 is disrupted by multiple Parkinson\u2019s disease-associated mutations and regulates cytoplasmic localization. Biochem. J. 430, 393\u2013404 (2010).","journal-title":"Biochem. J."},{"key":"62337_CR72","doi-asserted-by":"publisher","first-page":"E34","DOI":"10.1073\/pnas.1312701111","volume":"111","author":"K Muda","year":"2014","unstructured":"Muda, K. et al. Parkinson-related LRRK2 mutation R1441C\/G\/H impairs PKA phosphorylation of LRRK2 and disrupts its interaction with 14-3-3. Proc. Natl. Acad. Sci. USA 111, E34\u2013E43 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"62337_CR73","doi-asserted-by":"publisher","first-page":"e17153","DOI":"10.1371\/journal.pone.0017153","volume":"6","author":"X Li","year":"2011","unstructured":"Li, X. et al. Phosphorylation-dependent 14-3-3 binding to LRRK2 is impaired by common mutations of familial Parkinson\u2019s disease. PLoS ONE 6, e17153 (2011).","journal-title":"PLoS ONE"},{"key":"62337_CR74","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aar5429","volume":"10","author":"R Di Maio","year":"2018","unstructured":"Di Maio, R. et al. LRRK2 activation in idiopathic Parkinson\u2019s disease. Sci. Transl. Med. 10, eaar5429 (2018).","journal-title":"Sci. Transl. Med."},{"key":"62337_CR75","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0092-8674(00)81067-3","volume":"84","author":"AJ Muslin","year":"1996","unstructured":"Muslin, A. J., Tanner, J. W., Allen, P. M. & Shaw, A. S. Interaction of 14-3-3 with signaling proteins is mediated by the recognition of phosphoserine. Cell 84, 889\u2013897 (1996).","journal-title":"Cell"},{"key":"62337_CR76","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1126\/science.aay0543","volume":"366","author":"Y Kondo","year":"2019","unstructured":"Kondo, Y. et al. Cryo-EM structure of a dimeric B-Raf:14-3-3 complex reveals asymmetry in the active sites of B-Raf kinases. Science 366, 109\u2013115 (2019).","journal-title":"Science"},{"key":"62337_CR77","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/s41586-019-1660-y","volume":"575","author":"E Park","year":"2019","unstructured":"Park, E. et al. Architecture of autoinhibited and active BRAF\u2013MEK1\u201314-3-3 complexes. Nature 575, 545\u2013550 (2019).","journal-title":"Nature"},{"key":"62337_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38864-0","volume":"14","author":"H Torosyan","year":"2023","unstructured":"Torosyan, H. et al. Structural insights into regulation of the PEAK3 pseudokinase scaffold by 14-3-3. Nat. Commun. 14, 3543 (2023).","journal-title":"Nat. Commun."},{"key":"62337_CR79","doi-asserted-by":"publisher","unstructured":"Martinez Fiesco, J. A., Durrant, D. E., Morrison, D. K. & Zhang, P. Structural insights into the BRAF monomer-to-dimer transition mediated by RAS binding. Nat. Commun. https:\/\/doi.org\/10.1038\/s41467-022-28084-3 (2022).","DOI":"10.1038\/s41467-022-28084-3"},{"key":"62337_CR80","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1021\/pr9008578","volume":"9","author":"CJ Gloeckner","year":"2010","unstructured":"Gloeckner, C. J. et al. Phosphopeptide analysis reveals two discrete clusters of phosphorylation in the N-terminus and the Roc domain of the Parkinson-disease associated protein kinase LRRK2. J. Proteome Res. 9, 1738\u20131745 (2010).","journal-title":"J. Proteome Res."},{"key":"62337_CR81","doi-asserted-by":"publisher","unstructured":"Manschwetus, J. T. et al. Binding of the human 14-3-3 isoforms to distinct sites in the leucine-rich repeat kinase 2. Front. Neurosci. https:\/\/doi.org\/10.3389\/fnins.2020.00302 (2020).","DOI":"10.3389\/fnins.2020.00302"},{"key":"62337_CR82","doi-asserted-by":"publisher","unstructured":"Cornell, B. & Toyo-Oka, K. 14-3-3 proteins in brain development: neurogenesis, neuronal migration and neuromorphogenesis. Front. Mol. Neurosci. https:\/\/doi.org\/10.3389\/fnmol.2017.00318 (2017).","DOI":"10.3389\/fnmol.2017.00318"},{"key":"62337_CR83","doi-asserted-by":"publisher","first-page":"17237","DOI":"10.1073\/pnas.0605779103","volume":"103","author":"X Yang","year":"2006","unstructured":"Yang, X. et al. Structural basis for protein\u2013protein interactions in the 14-3-3 protein family. Proc. Natl. Acad. Sci. USA 103, 17237\u201317242 (2006).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"62337_CR84","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.semcdb.2011.08.003","volume":"22","author":"A Aitken","year":"2011","unstructured":"Aitken, A. Post-translational modification of 14-3-3 isoforms and regulation of cellular function. Semin. Cell Dev. Biol. 22, 673\u2013680 (2011).","journal-title":"Semin. Cell Dev. Biol."},{"key":"62337_CR85","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1093\/bioinformatics\/btv133","volume":"31","author":"F Madeira","year":"2015","unstructured":"Madeira, F. et al. 14-3-3-Pred: improved methods to predict 14-3-3-binding phosphopeptides. Bioinformatics 31, 2276\u20132283 (2015).","journal-title":"Bioinformatics"},{"key":"62337_CR86","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1042\/BCJ20160557","volume":"473","author":"G Ito","year":"2016","unstructured":"Ito, G. et al. Phos-tag analysis of Rab10 phosphorylation by LRRK2: a powerful assay for assessing kinase function and inhibitors. Biochem. J. 473, 2671\u20132685 (2016).","journal-title":"Biochem. J."},{"key":"62337_CR87","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1042\/BJ20121772","volume":"456","author":"E Lobbestael","year":"2013","unstructured":"Lobbestael, E. et al. Identification of protein phosphatase 1 as a regulator of the LRRK2 phosphorylation cycle. Biochem. J. 456, 119\u2013128 (2013).","journal-title":"Biochem. J."},{"key":"62337_CR88","doi-asserted-by":"publisher","first-page":"14498","DOI":"10.1021\/jacs.8b09618","volume":"140","author":"LM Stevers","year":"2018","unstructured":"Stevers, L. M., De Vink, P. J., Ottmann, C., Huskens, J. & Brunsveld, L. A thermodynamic model for multivalency in 14-3-3 protein\u2013protein interactions. J. Am. Chem. Soc. 140, 14498\u201314510 (2018).","journal-title":"J. Am. Chem. Soc."},{"key":"62337_CR89","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adk6191","volume":"9","author":"M Sanz Murillo","year":"2023","unstructured":"Sanz Murillo, M. et al. Inhibition of Parkinson\u2019s disease-related LRRK2 by type I and type II kinase inhibitors: activity and structures. Sci. Adv. 9, eadk6191 (2023).","journal-title":"Sci. Adv."},{"key":"62337_CR90","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1002\/mds.22365","volume":"24","author":"ST Camargos","year":"2009","unstructured":"Camargos, S. T. et al. Familial Parkinsonism and early onset Parkinson\u2019s disease in a Brazilian movement disorders clinic: phenotypic characterization and frequency of SNCA, PRKN, PINK1, and LRRK2 mutations. Mov. Disord. 24, 662\u2013666 (2009).","journal-title":"Mov. Disord."},{"key":"62337_CR91","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1042\/BCJ20161078","volume":"474","author":"LM Stevers","year":"2017","unstructured":"Stevers, L. M. et al. Structural interface between LRRK2 and 14-3-3 protein. Biochem. J. 474, 1273\u20131287 (2017).","journal-title":"Biochem. J."},{"key":"62337_CR92","doi-asserted-by":"publisher","unstructured":"Karlberg, T. et al. 14-3-3 proteins activate Pseudomonas exotoxins-S and -T by chaperoning a hydrophobic surface. Nat. Commun. https:\/\/doi.org\/10.1038\/s41467-018-06194-1 (2018).","DOI":"10.1038\/s41467-018-06194-1"},{"key":"62337_CR93","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1038\/s41594-022-00863-y","volume":"29","author":"DM Snead","year":"2022","unstructured":"Snead, D. M. et al. Structural basis for Parkinson\u2019s disease-linked LRRK2\u2019s binding to microtubules. Nat. Struct. Mol. Biol. 29, 1196\u20131207 (2022).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"62337_CR94","doi-asserted-by":"publisher","unstructured":"Alessi, D. R. & Pfeffer, S. R. Leucine-rich repeat kinases. Annu. Rev. Biochem. https:\/\/doi.org\/10.1146\/annurev-biochem-030122-051144 (2024).","DOI":"10.1146\/annurev-biochem-030122-051144"},{"key":"62337_CR95","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nmeth.4169","volume":"14","author":"A Punjani","year":"2017","unstructured":"Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290\u2013296 (2017).","journal-title":"Nat. Methods"},{"key":"62337_CR96","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1042\/BCJ20220161","volume":"479","author":"AF Kalogeropulou","year":"2022","unstructured":"Kalogeropulou, A. F. et al. Impact of 100 LRRK2 variants linked to Parkinson\u2019s disease on kinase activity and microtubule binding. Biochem. J. 479, 1759\u20131783 (2022).","journal-title":"Biochem. J."},{"key":"62337_CR97","first-page":"1","volume":"2017","author":"Y Zhang","year":"2017","unstructured":"Zhang, Y. et al. Genetic analysis of LRRK2 R1628P in Parkinson\u2019s disease in Asian populations. Parkinsons Dis. 2017, 1\u20136 (2017).","journal-title":"Parkinsons Dis."},{"key":"62337_CR98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/867321","volume":"2014","author":"AA Gopalai","year":"2014","unstructured":"Gopalai, A. A. et al. LRRK2 G2385R and R1628P mutations are associated with an increased risk of Parkinson\u2019s disease in the Malaysian population. BioMed. Res. Int. 2014, 1\u20134 (2014).","journal-title":"BioMed. Res. Int."},{"key":"62337_CR99","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1042\/BJ20100483","volume":"430","author":"R","year":"2010","unstructured":"R et al. 14-3-3 binding to LRRK2 is disrupted by multiple Parkinson\u2019s disease-associated mutations and regulates cytoplasmic localization. Biochem. J. 430, 393\u2013404 (2010).","journal-title":"Biochem. J."},{"key":"62337_CR100","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2100844118","volume":"118","author":"SH Schmidt","year":"2021","unstructured":"Schmidt, S. H. et al. Conformation and dynamics of the kinase domain drive subcellular location and activation of LRRK2. Proc. Natl. Acad. Sci. USA 118, e2100844118 (2021).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"62337_CR101","doi-asserted-by":"publisher","unstructured":"Metcalfe, R. D. et al. Structure and regulation of full-length human leucine-rich repeat kinase 1. Nat. Commun. https:\/\/doi.org\/10.1038\/s41467-023-40532-2 (2023).","DOI":"10.1038\/s41467-023-40532-2"},{"key":"62337_CR102","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/jnc.12798","volume":"131","author":"L Reyniers","year":"2014","unstructured":"Reyniers, L. et al. Differential protein\u2013protein interactions of LRRK1 and LRRK2 indicate roles in distinct cellular signaling pathways. J. Neurochem. 131, 239\u2013250 (2014).","journal-title":"J. Neurochem."},{"key":"62337_CR103","doi-asserted-by":"publisher","unstructured":"Kelly, K. & West, A. B. Pharmacodynamic biomarkers for emerging LRRK2 therapeutics. Front. Neurosci. https:\/\/doi.org\/10.3389\/fnins.2020.00807 (2020).","DOI":"10.3389\/fnins.2020.00807"},{"key":"62337_CR104","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1042\/BCJ20200930","volume":"478","author":"RS Nirujogi","year":"2021","unstructured":"Nirujogi, R. S. et al. Development of a multiplexed targeted mass spectrometry assay for LRRK2-phosphorylated Rabs and Ser910\/Ser935 biomarker sites. Biochem. J. 478, 299\u2013326 (2021).","journal-title":"Biochem. J."},{"key":"62337_CR105","doi-asserted-by":"publisher","first-page":"623","DOI":"10.3233\/JPD-191786","volume":"10","author":"S Padmanabhan","year":"2020","unstructured":"Padmanabhan, S. et al. An assessment of LRRK2 serine 935 phosphorylation in human peripheral blood mononuclear cells in idiopathic Parkinson\u2019s disease and G2019S LRRK2 cohorts. J. Parkinson Dis. 10, 623\u2013629 (2020).","journal-title":"J. Parkinson Dis."},{"key":"62337_CR106","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1111\/cts.13541","volume":"16","author":"MFJM Vissers","year":"2023","unstructured":"Vissers, M. F. J. M. et al. A leucine-rich repeat kinase 2 (LRRK2) pathway biomarker characterization study in patients with Parkinson\u2019s disease with and without LRRK2 mutations and healthy controls. Clin. Transl. Sci. 16, 1408\u20131420 (2023).","journal-title":"Clin. Transl. Sci."},{"key":"62337_CR107","doi-asserted-by":"publisher","unstructured":"Taymans, J.-M. et al. Perspective on the current state of the LRRK2 field. npj Parkinson Dis. https:\/\/doi.org\/10.1038\/s41531-023-00544-7 (2023).","DOI":"10.1038\/s41531-023-00544-7"},{"key":"62337_CR108","first-page":"249","volume":"78","author":"L Iralde-Lorente","year":"2021","unstructured":"Iralde-Lorente, L., Botta, M. & Ottmann, C. Small-molecule modulators of protein-protein interactions: focus on 14-3-3 PPIs. Drug Discov. Ser.78, 249\u2013279 (2021).","journal-title":"Drug Discov. Ser."},{"key":"62337_CR109","doi-asserted-by":"publisher","unstructured":"Somsen, B. A., Cossar, P. J., Arkin, M. R., Brunsveld, L. & Ottmann, C. 14-3-3 protein-protein interactions: from mechanistic understanding to their small-molecule stabilization. Chembiochem https:\/\/doi.org\/10.1002\/cbic.202400214 (2024).","DOI":"10.1002\/cbic.202400214"},{"key":"62337_CR110","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.chembiol.2024.04.002","volume":"31","author":"M Konstantinidou","year":"2024","unstructured":"Konstantinidou, M. & Arkin, M. R. Molecular glues for protein-protein interactions: progressing toward a new dream. Cell Chem. Biol. 31, 1064\u20131088 (2024).","journal-title":"Cell Chem. Biol."},{"key":"62337_CR111","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.1038\/nprot.2014.173","volume":"9","author":"A Goehring","year":"2014","unstructured":"Goehring, A. et al. Screening and large-scale expression of membrane proteins in mammalian cells for structural studies. Nat. Protoc. 9, 2574\u20132585 (2014).","journal-title":"Nat. Protoc."},{"key":"62337_CR112","doi-asserted-by":"publisher","unstructured":"Bepler, T., Kelley, K., Noble, A. J. & Berger, B. Topaz-Denoise: general deep denoising models for cryoEM and cryoET. Nat. Commun. https:\/\/doi.org\/10.1038\/s41467-020-18952-1 (2020).","DOI":"10.1038\/s41467-020-18952-1"},{"key":"62337_CR113","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1038\/s41592-019-0575-8","volume":"16","author":"T Bepler","year":"2019","unstructured":"Bepler, T. et al. Positive-unlabeled convolutional neural networks for particle picking in cryo-electron micrographs. Nat. Methods 16, 1153\u20131160 (2019).","journal-title":"Nat. Methods"},{"key":"62337_CR114","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1038\/s41592-020-00990-8","volume":"17","author":"A Punjani","year":"2020","unstructured":"Punjani, A., Zhang, H. & Fleet, D. J. Non-uniform refinement: adaptive regularization improves single-particle cryo-EM reconstruction. Nat. Methods 17, 1214\u20131221 (2020).","journal-title":"Nat. Methods"},{"key":"62337_CR115","doi-asserted-by":"publisher","first-page":"107702","DOI":"10.1016\/j.jsb.2021.107702","volume":"213","author":"A Punjani","year":"2021","unstructured":"Punjani, A. & Fleet, D. 3D variability analysis: resolving continuous flexibility and discrete heterogeneity from single particle cryo-EM. J. Struct. Biol. 213, 107702 (2021).","journal-title":"J. Struct. Biol."},{"key":"62337_CR116","doi-asserted-by":"publisher","unstructured":"Sanchez-Garcia, R. et al. DeepEMhancer: a deep learning solution for cryo-EM volume post-processing. Commun. Biol. https:\/\/doi.org\/10.1038\/s42003-021-02399-1 (2021).","DOI":"10.1038\/s42003-021-02399-1"},{"key":"62337_CR117","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen, E. F. et al. UCSF Chimera\u2014a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605\u20131612 (2004).","journal-title":"J. Comput. Chem."},{"key":"62337_CR118","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. Sect. D Biol. Crystallogr. 66, 486\u2013501 (2010).","journal-title":"Acta Crystallogr. Sect. D Biol. Crystallogr."},{"key":"62337_CR119","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1107\/S2059798319011471","volume":"75","author":"D Liebschner","year":"2019","unstructured":"Liebschner, D. et al. Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix. Acta Crystallogr. Sect. D Struct. Biol. 75, 861\u2013877 (2019).","journal-title":"Acta Crystallogr. Sect. D Struct. Biol."},{"key":"62337_CR120","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1107\/S2059798318006551","volume":"74","author":"PV Afonine","year":"2018","unstructured":"Afonine, P. V. et al. Real-space refinement in PHENIX for cryo-EM and crystallography. Acta Crystallogr. Sect. D Struct. Biol. 74, 531\u2013544 (2018).","journal-title":"Acta Crystallogr. Sect. D Struct. Biol."},{"key":"62337_CR121","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/pro.3330","volume":"27","author":"CJ Williams","year":"2018","unstructured":"Williams, C. J. et al. MolProbity: More and better reference data for improved all-atom structure validation. Protein Sci. 27, 293\u2013315 (2018).","journal-title":"Protein Sci."},{"key":"62337_CR122","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/pro.3943","volume":"30","author":"EF Pettersen","year":"2021","unstructured":"Pettersen, E. F. et al. UCSF ChimeraX: structure visualization for researchers, educators, and developers. Protein Sci. 30, 70\u201382 (2021).","journal-title":"Protein Sci."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62337-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62337-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62337-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T15:03:52Z","timestamp":1757343832000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62337-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,5]]},"references-count":122,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["62337"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-62337-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.11.22.624879","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,5]]},"assertion":[{"value":"11 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7226"}}